Tardive Dyskinesia
Tardive Dyskinesia (TD) is a movement disorder resulting from prolonged use of certain medications, often with psychiatric implications. The Journal of Clinical Psychiatry offers comprehensive insights into TD, from its pathophysiology to management strategies. Our expert editors ensure that the content is both clinically relevant and actionable, aiding psychiatrists in diagnosing, preventing, and treating this challenging condition.
How Tardive Dyskinesia Impacts Patients Using Antipsychotics
An expert explains the mechanism, risk factors, progression, and quality of life implications of Tardive Dyskinesia.
A Reason for Hope in Rett Syndrome: New Medications, Novel Gene Therapies
Some emerging therapies and treatment options hold promise in Rett Syndrome, a rare neurodevelopmental disorder that primarily affects girls.
New Scale Measures True Impact of Tardive Dyskinesia
A panel of experts has developed an easy-to-use scale to assess the symptoms and challenges of having tardive dyskinesia.
Recent JCP Articles
Impact of Tardive Dyskinesia on Physical, Psychological, Social, and Professional Domains of Patient Lives: A Survey of Patients in the United States
This survey reveals the substantial burden of tardive dyskinesia on people’s lives and on the management of their underlying condition.
Impact-Tardive Dyskinesia (Impact-TD) Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia
This easy-to-use scale developed by 7 experts measures the impact of TD on patients’ daily functioning.
Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan
This study compared spontaneous reporting of tardive dyskinesia with long-acting injectable versus oral antipsychotics.
Recent PCC Articles
Prevalence of Tardive Dyskinesia in an Electronic Medical Record Study at a Large Community Mental Health Treatment Center
This study examined clinician documentation of tardive dyskinesia in a large electronic medical record database from a single large community mental health treatment center.
Electroconvulsive Therapy as a Treatment for Tardive Dyskinesia
ECT may be a successful treatment for some cases of tardive dyskinesia. In this review, the authors accumulate all the recent evidence for the efficacy of ECT in treating tardive dyskinesia and make recommendations following data analysis.
Quetiapine for the Management of Tardive Dyskinesia in Schizoaffective Disorder Comorbid With Diabetes Mellitus and Chronic Kidney Disease
In this report, the authors describe the successful management of tardive dyskinesia with quetiapine in a man with schizoaffective disorder and comorbid diabetes with renal and neurologic complications as well as hypothyroidism and hypertension.
